Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
about
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueCYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropionAnimal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletionsMolecular genetics of successful smoking cessation: convergent genome-wide association study resultsRisk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropionBacoside A: Role in Cigarette Smoking Induced Changes in BrainPreclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotypeTobacco addiction and the dysregulation of brain stress systems.New mechanisms and perspectives in nicotine withdrawalGene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomesThe atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitorsEffects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawalGalantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesSynthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET studyEffects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigmIdentification and Structural Characterization of Three New Metabolites of Bupropion in HumansThe antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.Bupropion: pharmacology and therapeutic applications.Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.Chiral toxicology: it's the same thing...only different.Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.Monoamine reuptake inhibitors in Parkinson's disease.Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.Resolution of enantiomers of bupropion and its metabolites by liquid chromatography.Effects of menthol on the pharmacokinetics of bupropion among Black smokers.Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioningThe corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders.Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Bupropion for the treatment of nicotine withdrawal and craving.The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats
P2860
Q24615008-E648EDC6-0CB6-48DA-B293-99CF6730F69CQ24634660-03820050-CA31-4DF5-9A8A-D657D492819AQ24651067-EBE116BA-595B-485B-B45F-80A2272F717FQ24653819-119CE3CB-4D09-4831-9795-EEAE7E0149B8Q26776311-F9825546-2E40-4D3D-AD48-D97DD6D5EEFAQ26786019-7DDE50ED-1558-4C98-9F9D-2BDF63205E33Q27021772-F250F3A1-0570-4331-BDCA-D58B8E433252Q28111988-A292103B-446F-48E1-B0E5-C3A474F8F008Q28111991-293FF63F-DB65-45A8-A235-57EA394B873BQ28247305-BEB0AF1F-2F9A-402A-8338-EACBC2653B1CQ28477546-1FCC447C-54A1-447F-8862-66F2FEF70C78Q30433175-D2320981-E278-4678-AD8E-7657D19DE559Q30446699-4117FF80-BAA4-40E6-A7F6-80074BFD9F65Q30476918-8507EFC9-E582-457B-9A93-DD59150A5C28Q30657759-539401C1-4B0F-48A6-BB00-5BE93589ED59Q33738559-6AABFD74-2EED-4123-85E1-17070886CEF9Q33955964-65BF3229-5595-49CB-AD05-46C4893B21D7Q34054242-D942A438-5176-40DA-8B75-EEDD966CBB7EQ34128836-B658D3BE-B51B-4EAD-A5DD-4B48B85E5A6AQ34164440-E83D5D99-C2AB-44F4-B417-A6971CE7B151Q34215376-E5248F16-2025-43D5-80A0-CBB3792E1616Q34394190-721414CA-17ED-4806-AD0A-E96022B9B013Q34425063-EBD7C59D-B7AC-4ADA-9068-32E95212C26FQ34540994-6931867C-6ED2-4CB7-9BC5-2D306C9E3098Q34541188-1A13DF1A-BBED-4EDE-B271-5388030F60F9Q34569990-0AFB349C-E07E-453F-8D97-4A6F5B5B6F7BQ34602596-6C721718-9F84-4023-A138-E65E2CB1CF79Q34979115-49111C5C-D9D4-4CB5-B564-7FB12868B907Q35089573-AA89ADFF-E2BE-4DEC-A8D3-0E5ED87F10A1Q35165280-CEB837D2-EE81-48E1-AF8C-4AE6D87ECFE7Q35545542-3F4F8AF8-2001-4F8C-8E89-07AF57096A42Q35731310-784A9A00-42C0-41A0-B1D3-603AE4EFFC53Q35972921-D1438629-F003-48F3-8A2B-AD7D3D1899DEQ36103496-31A4C191-A8DC-46C6-8BD7-7D7C8BCFFD06Q36219686-A7CB1379-3791-406D-8A46-F450A75C8D1CQ36349942-C2C6CC40-D49F-4D10-B098-240A9DFED1E1Q36372867-C6962E83-468C-4AED-B644-485659E1C92BQ36511661-484FF2CD-9D3C-42BB-9924-B9354ADB1CC6Q36532139-7ACBD58E-9388-40F6-8D18-06A630D1DA82Q36534965-8F269F05-70F4-479A-88B4-9C5DDCF02F63
P2860
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Enantioselective effects of hy ...... rters and nicotinic receptors.
@ast
Enantioselective effects of hy ...... rters and nicotinic receptors.
@en
Enantioselective effects of hy ...... rters and nicotinic receptors.
@nl
type
label
Enantioselective effects of hy ...... rters and nicotinic receptors.
@ast
Enantioselective effects of hy ...... rters and nicotinic receptors.
@en
Enantioselective effects of hy ...... rters and nicotinic receptors.
@nl
prefLabel
Enantioselective effects of hy ...... rters and nicotinic receptors.
@ast
Enantioselective effects of hy ...... rters and nicotinic receptors.
@en
Enantioselective effects of hy ...... rters and nicotinic receptors.
@nl
P2093
P356
P1476
Enantioselective effects of hy ...... rters and nicotinic receptors.
@en
P2093
Billy R Martin
Bruce E Blough
F Ivy Carroll
Hernan A Navarro
J Brek Eaton
M Imad Damaj
Ronald J Lukas
Sadiq Mirza
P304
P356
10.1124/MOL.104.001313
P577
2004-09-01T00:00:00Z